Leukemia Inhibitory Factor (LIF) Peptide
-
- Antigène Tous les produits LIF
- LIF (Leukemia Inhibitory Factor (LIF))
- Origine
- Humain, Rat, Souris, Porc, Mouton, Boeuf (Vache)
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-LIF Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- LIF (Leukemia Inhibitory Factor (LIF))
- Synonymes
- CDF Peptide, DIA Peptide, HILDA Peptide, MLPLI Peptide, LIF, interleukin 6 family cytokine Peptide, leukemia inhibitory factor Peptide, LIF Peptide, Lif Peptide
- Sujet
- HILDA, Leukemia inhibitory factor, LIF, Differentiation-stimulating factor, D factor, Melanoma-derived LPL inhibitor, MLPLI, Emfilermin
- ID gène
- 3976, 16878
- UniProt
- P15018, P09056, P17777
-